Prostate Cancer Treatment Wyoming MI
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Univ Of Mi Med Sch, Ann Arbor Mi 48109
Graduation Year: 1993
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Mi Med Sch, Ann Arbor Mi 48109
Graduation Year: 1995
Radiation Oncology
Grand Rapids, MI
Oncology (Cancer), Radiation Oncology
Gender
Male
Languages
French, Spanish, Chinese, Other
Education
Medical School: Univ Indonesia, Fac Of Med, Jakarta, Jawa Barat, Indonesia
Graduation Year: 1961
Hospital
Hospital: Spectrum Health -East Campus, Grand Rapids, Mi
Pediatric Hematology-Oncology
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Wayne State Univ Sch Of Med, Detroit Mi 48201
Graduation Year: 1976
Hospital
Hospital: Spectrum Health, Grand Rapids, Mi; Spectrum Health -East Campus, Grand Rapids, Mi
Group Practice: Medical Speciality Assoc
M
Education
Medical School: Mi State Univ Coll Of Human Med
Year of Graduation: 1997
Speciality
Oncologist
General Information
Hospital: Mary Free Bed Hospital And Reh, Grand Rapids, Mi
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 1, reviews.
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Ks Sch Of Med, Kansas City Ks 66103
Graduation Year: 1996
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Ks Sch Of Med, Kansas City Ks 66103
Graduation Year: 1987
Radiation Oncology
Heal Thyself—Prostate Cancer
By Barbara Hey
Turning up the heat may provide a less invasive, more promising treatment for prostate cancer. Blasting the cancer with a treatment that uses high-intensity focused ultrasound (HIFU) to kill cancer cells and surrounding prostate tissue offers myriad benefits over conventional treatments according to John Warner, MD, the medical director of the Maple Leaf HIFU Company in Vancouver, British Columbia. Maple Leaf HIFU manufactures Ablatherm HIFU, the machine currently used for this procedure.
• HIFU can be performed under a spinal block—versus general anesthesia—most often on an outpatient basis, Warner explains, with no incision and no attendant loss of blood. Studies confirm HIFU’s effectiveness in combating the disease, and because it’s noninvasive, the procedure is less likely to damage surrounding nerves and tissue. A study published in the Journal of Urology in 2003 found that five years after treatment, 87 percent of patients had stable prostate specific antigen (PSA) levels. High or rising levels suggest the presence of the disease.
• If treated early, before it spreads, prostate cancer has a nearly 100 percent five-year survival rate, according to the Prostate Cancer Foundation. Though the common methods of treatment (radiation and surgery) work effectively, they have a number of ser-ious risks associated with them. With radiation administered externally—called external beam radiotherapy—the beam can damage surrounding tissue, skin, and muscle en route to the prostate, and patients commonly require multiple treatments. Another option is brachytherapy in which radioactive pellets are inserted surgically into the prostate. The risk of this type of radiation is that the effects can extend beyond the prostate itself. A third option, surgery, requires general anesthesia and hospitalization, which both carry risks. A much more aggressive tactic, surgery involves not just removal of the prostate, but also portions of the seminal ducts and part of the bladder. Common aftereffects of all these treatments include impotence and incontinence.
• For the HIFU treatment, a probe is inserted in the rectum to guide the ultrasound to the prostate using computer imaging. The focused beam of sound reaches a heat of 85 degrees Celsius, killing the cells of the prostate (dead tissue is excreted later in the urine) while skirting the surrounding nerves and muscles. And according to Warner, 90 percent of the patients require just one treatment, which may last 90 minutes to three hours.
• Currently only the Don Mills Surgical Unit in Toronto offers Ablatherm HIFU treatment, but that may change in the near future. FDA-monitored studies comparing HIFU with cryotherapy (freezing the tissue, commonly used as a second-line of treatment) on patients with a recurrence of the disease will begin in 2006, setting the stage for the treatment to one day be available in the US.
Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...

